Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,493,348
-$1,003,261 QoQ
Shares Held
35,052
-17.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#251
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. NVS ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,493,348 | 35,052 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,496,609 | 42,531 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $801,713 | 5,815 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $800,217 | 6,240 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $791,404 | 6,540 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,869,198 | 52,648 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,190,040 | 73,888 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,885,328 | 120,721 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $754,481 | 7,087 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,206,073 | 115,849 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,324,088 | 112,153 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $11,552,349 | 113,414 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,764,674 | 106,676 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,970,184 | 97,502 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,512,166 | 93,829 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,190,773 | 94,603 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,498,104 | 41,383 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,466,300 | 39,502 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,992,261 | 34,209 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,724,827 | 33,319 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,794,498 | 30,628 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,356,256 | 27,565 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,666,325 | 28,236 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $54,348,782 | 624,986 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $23,255,148 | 266,260 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $32,709,234 | 396,716 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||